SAFETY AND TOLERANCE DATA FROM THE BELGIAN MULTICENTER STUDY OF ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX VERSUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION

被引:22
作者
BOSSAERT, LL
机构
关键词
D O I
10.2165/00003495-198700333-00055
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:287 / 292
页数:6
相关论文
共 8 条
[1]   INTRAVENOUS STREPTOKINASE IN EVOLVING ACUTE MYOCARDIAL-INFARCTION [J].
GANZ, W ;
GEFT, I ;
SHAH, PK ;
LEW, AS ;
RODRIGUEZ, L ;
WEISS, T ;
MADDAHI, J ;
BERMAN, DS ;
CHARUZI, Y ;
SWAN, HJC .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (09) :1209-1216
[2]   WESTERN WASHINGTON RANDOMIZED TRIAL OF INTRACORONARY STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION [J].
KENNEDY, JW ;
RITCHIE, JL ;
DAVIS, KB ;
FRITZ, JK .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (24) :1477-1482
[3]   ANALYSIS OF COAGULATION AND FIBRINOLYSIS AFTER INTRAVENOUS ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX OR HEPARIN IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - A BELGIAN MULTICENTER STUDY [J].
RENKIN, J ;
COLDEBEYS, C ;
LAVENNEPARDONGE, E ;
PINTENS, H ;
COL, J .
DRUGS, 1987, 33 :253-260
[4]  
SIMOONS ML, 1985, LANCET, V2, P578
[6]  
The Thrombolysis In Myocardial Infarction (TIMI) trial, 1985, NEW ENGLAND J MED, V312, P932
[7]   RANDOMIZED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION [J].
VERSTRAETE, M ;
BORY, M ;
COLLEN, D ;
ERBEL, R ;
LENNANE, RJ ;
MATHEY, D ;
MICHELS, HR ;
SCHARTL, M ;
UEBIS, R ;
BERNARD, R ;
BROWER, RW ;
DEBONO, DP ;
HUHMANN, W ;
LUBSEN, J ;
MEYER, J ;
RUTSCH, W ;
SCHMIDT, W ;
VONESSEN, R .
LANCET, 1985, 1 (8433) :842-847
[8]  
VERSTRAETE M, 1985, LANCET, V2, P965